| Product Code: ETC10765518 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
India`s pemetrexed import market in 2024 continued to see a high level of concentration, with the top exporting countries being the USA, Metropolitan France, China, India, and Australia. The market experienced a significant compound annual growth rate (CAGR) of 37.68% from 2020 to 2024. However, there was a slight decline in growth rate from 2023 to 2024, with a rate of -6.76%. These trends indicate a dynamic and competitive landscape for pemetrexed imports in India, with opportunities for further market expansion and diversification in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Pemetrexed Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Pemetrexed Market Revenues & Volume, 2021 & 2031F |
3.3 India Pemetrexed Market - Industry Life Cycle |
3.4 India Pemetrexed Market - Porter's Five Forces |
3.5 India Pemetrexed Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 India Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 India Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2021 & 2031F |
3.8 India Pemetrexed Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 India Pemetrexed Market Revenues & Volume Share, By Administration Route, 2021 & 2031F |
4 India Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lung cancer in India |
4.2.2 Growing awareness about the benefits of pemetrexed in cancer treatment |
4.2.3 Government initiatives to improve healthcare infrastructure and access to advanced treatments |
4.3 Market Restraints |
4.3.1 High cost associated with pemetrexed therapy |
4.3.2 Stringent regulatory requirements for drug approval in India |
4.3.3 Limited availability of skilled healthcare professionals for administering pemetrexed treatment |
5 India Pemetrexed Market Trends |
6 India Pemetrexed Market, By Types |
6.1 India Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 India Pemetrexed Market Revenues & Volume, By Indication, 2021 - 2031F |
6.1.3 India Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021 - 2031F |
6.1.4 India Pemetrexed Market Revenues & Volume, By Mesothelioma, 2021 - 2031F |
6.1.5 India Pemetrexed Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.1.6 India Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.1.7 India Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2021 - 2031F |
6.2 India Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 India Pemetrexed Market Revenues & Volume, By Antifolate, 2021 - 2031F |
6.2.3 India Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2021 - 2031F |
6.2.4 India Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2021 - 2031F |
6.2.5 India Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2021 - 2031F |
6.2.6 India Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2021 - 2031F |
6.3 India Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 India Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2021 - 2031F |
6.3.3 India Pemetrexed Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.3.4 India Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.3.5 India Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.3.6 India Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.4 India Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India Pemetrexed Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 India Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.4.4 India Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.5 India Pemetrexed Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 India Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.5 India Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 India Pemetrexed Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.3 India Pemetrexed Market Revenues & Volume, By Injection, 2021 - 2031F |
6.5.4 India Pemetrexed Market Revenues & Volume, By IV Infusion, 2021 - 2031F |
6.5.5 India Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.5.6 India Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2021 - 2031F |
7 India Pemetrexed Market Import-Export Trade Statistics |
7.1 India Pemetrexed Market Export to Major Countries |
7.2 India Pemetrexed Market Imports from Major Countries |
8 India Pemetrexed Market Key Performance Indicators |
8.1 Number of clinical trials evaluating the efficacy of pemetrexed in different types of cancers |
8.2 Adoption rate of pemetrexed in oncology centers and hospitals |
8.3 Patient satisfaction and reported outcomes after pemetrexed treatment |
8.4 Rate of adverse reactions and side effects associated with pemetrexed therapy |
8.5 Investment in research and development for improved formulations or delivery methods of pemetrexed |
9 India Pemetrexed Market - Opportunity Assessment |
9.1 India Pemetrexed Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 India Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 India Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2021 & 2031F |
9.4 India Pemetrexed Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 India Pemetrexed Market Opportunity Assessment, By Administration Route, 2021 & 2031F |
10 India Pemetrexed Market - Competitive Landscape |
10.1 India Pemetrexed Market Revenue Share, By Companies, 2024 |
10.2 India Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here